Position in NVS
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$286,327
-$13,368 QoQ
Shares Held
1,827
-6.9% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1,156
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Global Trust Asset Management, LLC holds $9,434,621 across 13 Drug Manufacturers - General names. NVS ranks #6 (3.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
28,730 | $3,691,805 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
39,322 | $2,265,733 | |
| 3 | JNJ |
Johnson & Johnson
|
4,799 | $1,218,802 | |
| 4 | LLY |
ELI LILLY & Co
|
868 | $1,041,105 | |
| 5 | NVO |
Novo Nordisk A S
|
8,167 | $391,525 | |
| 6 | NVS |
Novartis AG
This page
|
1,827 | $286,327 | |
| 7 | ABBV |
AbbVie Inc.
|
787 | $198,040 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,449 | $183,066 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $286,327 | 1,827 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $299,695 | 1,962 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $302,486 | 2,194 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $345,222 | 2,692 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $326,969 | 2,702 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $314,596 | 2,822 | Shares | Sole | 2025-04-18 | |
| 2024-12-31 | $274,608 | 2,822 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $328,037 | 2,852 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $303,623 | 2,852 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $275,873 | 2,852 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $289,480 | 2,867 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $292,032 | 2,867 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $294,051 | 2,914 | Shares | Sole | 2023-07-24 | |
| 2023-03-31 | $268,088 | 2,914 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $282,864 | 3,118 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $242,167 | 3,186 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $275,905 | 3,264 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $295,015 | 3,362 | Shares | Sole | 2022-04-15 | |
| 2021-12-31 | $294,074 | 3,362 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $303,976 | 3,717 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $341,876 | 3,747 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $336,107 | 3,932 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $372,337 | 3,943 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $340,274 | 3,913 | Shares | Sole | 2020-11-17 | |
| 2020-06-30 | $341,761 | 3,913 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $322,626 | 3,913 | Shares | Sole | 2020-04-06 | |
| No filing history on record for this holder in this stock. | ||||||